EDGAR Filing Documents for 0001171843-15-001186

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001171843-15-001186

Filing Date

2015-03-02

Accepted

2015-03-02 17:06:13

Documents

Period of Report

2014-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	gff10k_030215.htm	10-K	926453
2	EXHIBIT 10.7	exh_107.htm	EX-10.7	56810
3	EXHIBIT 10.8	exh_108.htm	EX-10.8	42356
4	EXHIBIT 10.16	exh_1016.htm	EX-10.16	5991
5	EXHIBIT 10.42	exh_1042.htm	EX-10.42	1195
6	EXHIBIT 21	exh_21.htm	EX-21	2033
7	EXHIBIT 23	exh_23.htm	EX-23	11240
8	EXHIBIT 31.1	exh_311.htm	EX-31.1	5973
9	EXHIBIT 31.2	exh_312.htm	EX-31.2	6105
10	EXHIBIT 32.1	exh_321.htm	EX-32.1	4306
11	EXHIBIT 32.2	exh_322.htm	EX-32.2	4461
18	GRAPH	graph.jpg	GRAPHIC	60042
19	GRAPHIC	image_001.jpg	GRAPHIC	147956
20	GRAPHIC	image_002.jpg	GRAPHIC	68045
21	GRAPHIC	exh1016_1.jpg	GRAPHIC	282939
22	GRAPHIC	exh1016_2.jpg	GRAPHIC	331320
23	GRAPHIC	exh1016_3.jpg	GRAPHIC	320411
24	GRAPHIC	exh1016_4.jpg	GRAPHIC	343066
25	GRAPHIC	exh1016_5.jpg	GRAPHIC	348198
26	GRAPHIC	exh1016_6.jpg	GRAPHIC	308709
27	GRAPHIC	exh1016_7.jpg	GRAPHIC	164328
	Complete submission text file	0001171843-15-001186.txt		10548093

Data Files

Seq	Description	Document	Type	Size
12	XBRL INSTANCE FILE	bcrx-20141231.xml	EX-101.INS	925791
13	XBRL SCHEMA FILE	bcrx-20141231.xsd	EX-101.SCH	68491
14	XBRL CALCULATION FILE	bcrx-20141231_cal.xml	EX-101.CAL	37252
15	XBRL DEFINITION FILE	bcrx-20141231_def.xml	EX-101.DEF	318632
16	XBRL LABEL FILE	bcrx-20141231_lab.xml	EX-101.LAB	460052
17	XBRL PRESENTATION FILE	bcrx-20141231_pre.xml	EX-101.PRE	316734

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703

Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302

BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)